160 related articles for article (PubMed ID: 9484622)
1. Inherited susceptibility to breast and ovarian cancer.
Diamond TM; Sutphen R; Tabano M; Fiorica J
Curr Opin Obstet Gynecol; 1998 Feb; 10(1):3-8. PubMed ID: 9484622
[TBL] [Abstract][Full Text] [Related]
2. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
3. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
[TBL] [Abstract][Full Text] [Related]
4. The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.
Møller P; Borg A; Heimdal K; Apold J; Vallon-Christersson J; Hovig E; Maehle L; ;
Eur J Cancer; 2001 May; 37(8):1027-32. PubMed ID: 11334729
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
7. Genes implicated in hereditary breast cancer syndromes.
Tonin PN
Semin Surg Oncol; 2000 Jun; 18(4):281-6. PubMed ID: 10805949
[TBL] [Abstract][Full Text] [Related]
8. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.
Rubin SC; Blackwood MA; Bandera C; Behbakht K; Benjamin I; Rebbeck TR; Boyd J
Am J Obstet Gynecol; 1998 Apr; 178(4):670-7. PubMed ID: 9579428
[TBL] [Abstract][Full Text] [Related]
9. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.
Santarosa M; Dolcetti R; Magri MD; Crivellari D; Tibiletti MG; Gallo A; Tumolo S; Della Puppa L; Furlan D; Boiocchi M; Viel A
Int J Cancer; 1999 Sep; 83(1):5-9. PubMed ID: 10449599
[TBL] [Abstract][Full Text] [Related]
11. Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.
Rebbeck TR; Couch FJ; Kant J; Calzone K; DeShano M; Peng Y; Chen K; Garber JE; Weber BL
Am J Hum Genet; 1996 Sep; 59(3):547-53. PubMed ID: 8751855
[TBL] [Abstract][Full Text] [Related]
12. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
14. An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2.
Moslehi R; Russo D; Phelan C; Jack E; Antman K; Narod S
Clin Genet; 2000 Jan; 57(1):70-3. PubMed ID: 10733239
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to breast and ovarian cancer.
Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
[TBL] [Abstract][Full Text] [Related]
16. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC; Biesecker BB
Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
[TBL] [Abstract][Full Text] [Related]
18. Hereditary breast cancer.
Robson ME; Boyd J; Borgen PI; Cody HS
Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
[No Abstract] [Full Text] [Related]
19. The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.
Peelen T; Cornelis RS; van Vliet M; Petrij-Bosch A; Cleton-Jansen AM; Meijers-Heijboer H; Klijn JG; Vasen HF; Cornelisse CJ; Devilee P
Eur J Hum Genet; 1996; 4(4):225-30. PubMed ID: 8875189
[TBL] [Abstract][Full Text] [Related]
20. The genetics of breast and ovarian cancer.
Ford D; Easton DF
Br J Cancer; 1995 Oct; 72(4):805-12. PubMed ID: 7547224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
